AstraZeneca: Strong Q1 Earnings and Promising Pipeline Reinforce Buy Rating
TipRanksMay 2 14:17
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
TipRanksApr 30 14:21
BMO Capital raises AstraZeneca price target to $82
Gelonghui FinanceApr 29 10:50
AstraZeneca Analyst Ratings
BenzingaApr 27 02:02
BMO Capital Maintains Outperform on AstraZeneca, Raises Price Target to $82
BenzingaApr 27 02:02
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)
TipRanksApr 26 19:20
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
MT NewswiresApr 26 00:55
Analysts Have Conflicting Sentiments on These Healthcare Companies: Caliber Imaging & Diagnostic (OtherLCDX) and AstraZeneca (GB:AZN)
TipRanksApr 24 17:06
AstraZeneca Analyst Ratings
BenzingaApr 17 02:15
Deutsche Bank: Upgraded the AstraZeneca (AZN.US) rating from selling to holding.
Zhitong FinanceApr 17 02:20
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)
TipRanksApr 10 19:11
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), AstraZeneca (AZN)
TipRanksMar 27 21:40
AstraZeneca's Ultomiris Approval Spurs Buy Rating Amid Growth in Rare Disease Segment
TipRanksMar 27 17:15
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
TipRanksMar 21 14:51
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
MT NewswiresMar 20 23:40
Fusion Pharmaceuticals: Hold Rating Affirmed Post-AstraZeneca Acquisition Announcement
TipRanksMar 20 00:05
Fusion Pharmaceuticals: Hold Rating Amid AstraZeneca Acquisition and Radiopharmaceutical Prospects
TipRanksMar 19 22:15
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
TipRanksMar 19 14:21
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
MT NewswiresMar 15 16:55
AstraZeneca's Growth Potential Bolstered by Strong Pipeline and Strategic Acquisitions: A Buy Rating Justified
TipRanksFeb 22 13:17
No Data
No Data